Search Ontology:
ChEBI
pimavanserin tartrate
- Term ID
- CHEBI:133014
- Synonyms
-
- ACP 103
- ACP-103
- Bis(1-(4-Fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate
- bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate
- bis{N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea} (2R,3R)-2,3-dihydroxybutanedioate
- Nuplazid
- pimavanserin hemitartrate
- Definition
- A tartrate salt that is the hemitartrate salt of pimavanserin. An atypical antipsychotic that is used for treatment of hallucinations and delusions associated with Parkinson's disease.
- References
-
- cas:706782-28-7
- kegg.drug:D08969
- patent:NZ541146
- pubmed:16220333
- pubmed:16469866
- pubmed:16869120
- pubmed:17473118
- pubmed:17495279
- pubmed:17519387
- pubmed:17708779
- pubmed:18534670
- pubmed:19040345
- pubmed:19864614
- pubmed:21256805
- pubmed:26908168
- reaxys:10410569
- wikipedia.en:Pimavanserin
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from pimavanserin tartrate
Phenotype where environments contain pimavanserin tartrate
Phenotype modified by environments containing pimavanserin tartrate
Phenotype affecting pimavanserin tartrate
Human Disease Model